Oct 3, 2024 06:05AM
Oct 2, 2024 08:20PM
May 13, 2024 07:35AM
May 13, 2024 07:35AM
Oct 25, 2023 07:50AM
Oct 9, 2023 07:53AM
Oct 9, 2023 07:50AM Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
May 11, 2023 07:45AM
May 11, 2023 07:45AM
Mar 27, 2023 07:30AM
Mar 27, 2023 07:30AM
Mar 14, 2023 07:31AM
Mar 14, 2023 07:30AM
Mar 14, 2023 07:30AM Reneo Pharmaceuticals Achieves Target Enrollment in the Pivotal STRIDE Study of Mavodelpar (REN001) in Primary Mitochondrial Myopathies
Jan 31, 2023 07:35AM
Jan 31, 2023 07:35AM
Jan 31, 2023 07:35AM
Jul 26, 2022 07:34AM
Jul 26, 2022 07:30AM
Jul 26, 2022 07:30AM
Jul 28, 2021 08:00AM Reneo Pharmaceuticals Announces First Patient Dosed in the STRIDE Study
Jul 28, 2021 08:00AM

322,093 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All